United Kingdom· GB-APID-43207711000001104
Adjuvanted trivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes
A medicinal product containing influenza vaccine, registered in United Kingdom by Seqirus UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Influenza vaccine
- Manufacturer
- Seqirus UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin5060025639925
- gtin5060025631486
- gtin5060025639932
- gtin5060025631479
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f89334bd-ffd4-4bd3-bdf8-1099fcca8440 GET /v1/drugs/f89334bd-ffd4-4bd3-bdf8-1099fcca8440?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43207711000001104",
"desc": "Adjuvanted trivalent influenza vaccine (surface antigen, inactivated) suspension for injection 0.5ml pre-filled syringes (Seqirus UK Ltd)",
"form": "Suspension for injection",
"vpid": "37531311000001101",
"source": "dmd",
"vtm_id": "9894511000001108",
"strength": null,
"substance": "Influenza vaccine",
"ingredient": "Influenza virus surface antigens",
"supplier_code": "32816211000001105"
}See everything about influenza vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.